Year 2016 -
June 29, 2016
IPA Meeting with the FDA: Quality Forum Update, Washington DC.
May 13, 2016
Presentation to IGDRP: Licensing of Generic Products: Needs and Expectation of Industry, Strasbourg.
January 31, 2022
IPA Submission – USTR: 2021 Special 301 report
January 4, 2022
Global Innovation Summit 2021_Action report
March 2, 2022
Where’s the Indian pharma sector headed?
February 26, 2022
IPA’s 7th Global Pharma Quality Summit: Industry leaders & policymakers discuss best practices
February 25, 2022
Indian Pharmaceutical Alliance (IPA) organises 7th Global Pharmaceutical Quality Summit to share best practices in Sustainable Operations and Quality Excellence
February 25, 2022
IP Alliance kicks off 7th global pharma quality summit to disseminate best practices in sustainable operations & quality excellenc
February 25, 2022
Global Pharmaceutical Quality Summit Amplifies Conversations on Making Quality Pharmaceuticals in India, Sustainably, for the World
February 25, 2022
IPA organises seventh Global Pharmaceutical Quality Summit to share best practices in sustainable operations and quality excellence
February 25, 2022
Exclude cheap drugs from price control: IPA
February 24, 2022
Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary
February 21, 2022
India’s auto, pharma, engineering exports to UAE set to grow through trade pact: Govt
February 10, 2022
Vaccines, Biologics: Indian Pharma’s New Temptations
February 2, 2022
Budget: Health Allocation evokes mixed reaction from industry experts
January 30, 2022
Veterans Unpacked | Sudarshan Jain: “Adopt technology very fast and find the time to understanding it as much as possible”
January 27, 2022
Budget 2022 should fuel innovation in pharma industry
January 24, 2022
Innovation and technology to take India’s pharma industry to new heights in 2022
